Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon Rechallenge

Affiliations

¹ BScPharm, ACPR, is with the Department of Pharmacy, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta.
² BScPharm, PharmD, is with the Department of Pharmacy, Alberta Health Services, Calgary, Alberta.
³ MD, is with the Section of Dermatology, University of Calgary, Calgary, Alberta.
⁴ MD, FRCPC, is with the Section of Dermatology, University of Calgary, Calgary, Alberta.

Sarah Bonazza et al. Can J Hosp Pharm. 2015 Jul-Aug.

. 2015 Jul-Aug;68(4):339-41.

doi: 10.4212/cjhp.v68i4.1475.

¹ BScPharm, ACPR, is with the Department of Pharmacy, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta.
² BScPharm, PharmD, is with the Department of Pharmacy, Alberta Health Services, Calgary, Alberta.
³ MD, is with the Section of Dermatology, University of Calgary, Calgary, Alberta.
⁴ MD, FRCPC, is with the Section of Dermatology, University of Calgary, Calgary, Alberta.

No abstract available

References

1. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964;76:349–56. doi: 10.1111/j.1365-2133.1964.tb14541.x. - DOI - PubMed
1. Cohen PR. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34. doi: 10.1186/1750-1172-2-34. - DOI - PMC - PubMed
1. James WD, Berger TG, Elston DM. Andrews’ diseases of the skin: clinical dermatology. 11th ed. Saunders: Elsevier; 2011. Chapter 7: Erythema and urticaria; pp. 143–5.
1. Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42(10):761–78. doi: 10.1046/j.1365-4362.2003.01891.x. - DOI - PubMed
1. Wu AJ, Rodgers T, Fullen DR. Drug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest variant. J Cutan Pathol. 2008;35(2):220–4. - PubMed